Pelthos Therapeutics Inc.
Past financial statements no longer reliable (8-K Item 4.02)
The company stated in a Form 8-K (Item 4.02) filed on 13 Aug 2026 that previously issued financial statements should no longer be relied upon. This usually leads to a restatement of past results.
More details →Change of auditor (8-K Item 4.01)
The company reported a change of its independent auditor in a Form 8-K (Item 4.01) filed on 21 May 2026. Auditor changes are often routine (rotation, cost, mergers), but can follow disagreements over accounting.
More details →Pelthos Therapeutics Inc. — Overview & Financial Snapshot
Pelthos Therapeutics Inc. (NYSE American: PTHS) is a Healthcare company, ranked #6,677 of 6,774 companies globally and #3,913 of 4,000 in United States on PositoAI, with a Positivity Score of -43,290. Its market capitalisation is ₹707.93 Cr ($75.00M), P/E ratio is -0.7 and P/B ratio is -49.97. It has no active red flags (PosiRed) and 2 yellow flags (PosiYellow, 8/10 points): Past financial statements no longer reliable (8-K Item 4.02); Change of auditor (8-K Item 4.01).
For financial statements, ratio trends and score history, Go Deep →